What is the treatment for hip dysplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Developmental Dysplasia of the Hip

The primary treatment for developmental dysplasia of the hip (DDH) in infants up to 6 months of age is the Pavlik harness, which has a success rate of 67-83% when applied early, particularly before 6 weeks of age. 1

Age-Based Treatment Algorithm

Infants Under 6 Months

  1. Initial Diagnosis

    • 0-4 weeks: Clinical examination only; imaging not recommended for initial screening 1
    • 4 weeks-4 months: Ultrasound of the hips for suspected DDH 1
    • 4-6 months: Radiograph of the pelvis becomes the preferred imaging modality 1
  2. Treatment Approach

    • Mild instability: Many cases (60-80% identified on physical exam, >90% on ultrasound) resolve spontaneously 1
    • Confirmed DDH: Pavlik harness as first-line treatment 1, 2
      • Most effective when applied before 6 weeks of age
      • Can be used up to 6 months of age
      • Treatment duration typically 6-12 weeks
  3. Monitoring During Treatment

    • Serial physical examinations
    • Ultrasound for children <6 months to confirm concentric reduction 1
    • Radiographs near conclusion of treatment to document acetabular development 1

Older Infants and Children (>6 months)

  • Pavlik harness less effective; surgical intervention may be required
  • Options include:
    • Closed reduction and spica casting
    • Open reduction if closed reduction fails
    • Pelvic or femoral osteotomies for residual acetabular dysplasia 3

Effectiveness of Treatment

The Pavlik harness shows excellent results in properly selected cases:

  • 95.4% success rate reported in severe DDH when properly managed 2
  • Long-term studies show very low rates (2.81%) of residual dysplasia after 20+ years of follow-up 4
  • 90% of dislocated hips can be successfully reduced with proper harness use 2

Important Considerations and Pitfalls

  1. Proper Harness Selection and Application

    • Limited evidence supports von Rosen splint over Pavlik, Craig, or Frejka splints 1
    • Poor quality harness construction can contribute to treatment failure 5
  2. Monitoring Requirements

    • Regular clinical examinations out of the harness
    • Failure to achieve reduction must be recognized promptly 5
    • Ultrasound monitoring during treatment to confirm reduction 1
  3. Complications to Watch For

    • Avascular necrosis (1-30% of cases) 3, 5
    • Risk factors for avascular necrosis include:
      • Excessive hip abduction
      • Forceful closed reduction
      • Maintaining a dislocated hip in the harness 3
    • Femoral nerve palsy (rare)
  4. Treatment Failure Factors

    • Severity of initial hip dysplasia (Graf type IV or highly dislocated hips) 6
    • Treatment initiation after 3 months of age 6
    • Poor parent compliance with harness use 5
    • Improper harness application by physician 5

Special Situations

  • Graf Type IIc or Worse: Requires immediate treatment, with Pavlik harness as first-line approach 2, 4
  • Ortolani-Positive Hip: Requires immediate treatment 3
  • Stable Hip with Ultrasound Abnormalities: Limited evidence supports observation without bracing 1

By following this structured approach to DDH treatment with careful attention to age-appropriate interventions and proper monitoring, most cases can be successfully managed with excellent long-term outcomes and minimal complications.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.